(Q80396736)
Statements
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design (English)
Maurie Markman
Jonathan Markman
Kenneth Webster
Kristine Zanotti
Barbara Kulp
Gertrude Peterson
Jerome Belinson